Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails (Q37741773)

22 August 2017

1 reference

title

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails (English)

1 reference

22 August 2017

1 reference

Y Niu

1

1 reference

22 August 2017

T-M Chang

2

1 reference

22 August 2017

S Yeh

3

1 reference

22 August 2017

W-L Ma

4

1 reference

22 August 2017

Y Z Wang

5

1 reference

22 August 2017

C Chang

6

1 reference

22 August 2017

language of work or name

English

0 references

publication date

3 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

29

1 reference

22 August 2017

3593-3604

1 reference

22 August 2017

25

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.121

22 August 2017

0 references

cites work

Testosterone replacement therapy after primary treatment for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Selective Retention of Dihydrotestosterone by Prostatic Nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Tumor-stroma interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Contribution of the androgen receptor to prostate cancer predisposition and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

The role of the stromal microenvironment in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

The endocrinology and developmental biology of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Role of the stromal microenvironment in carcinogenesis of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Endocrine treatment in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen Receptor (AR) Coregulators: An Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Anti-cancer therapies targeting the tumor stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Trends in the leading causes of death in the United States, 1970-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Testosterone replacement therapy following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Inducible gene targeting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Molecular characterization of an improved vector for evaluation of the tumor suppressor versus oncogene abilities of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Prolonged control of progressive castration-resistant metastatic prostate cancer with testosterone replacement therapy: the case for a prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Targeting the stromal androgen receptor in primary prostate tumors at earlier stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Stem/progenitor and intermediate cell types and the origin of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Molecular characterization of human prostate carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptors in endocrine-therapy-resistant human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Expression of basal cell keratins in human prostate cancer metastases and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Use of nude mouse xenograft models in prostate cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor corepressors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Intermittent androgen suppression in the management of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

The Response of Metastatic Adenocarcinoma of the Prostate to Exogenous Testosterone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor (AR) coregulators: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen receptor status of lymph node metastases from prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Intermittent androgen suppression in prostate cancer: the Canadian experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Castration triggers growth of previously static androgen-independent lesions in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

TGF-beta in cancer and as a therapeutic target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Steroid hormones stimulate human prostate cancer progression and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Regulation of androgen action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.121

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.121

1 reference

Dimensions Publication ID

22 August 2017

0 references

1 reference